Table 4 Comparison of clinical outcomes during the follow-up period
Total | Group A (septic) | Group B (Aseptic) | p value† | |
|---|---|---|---|---|
(A) KOOS-JR scores | ||||
Pre-op | 38.8 ± 12.5 | 38.3 ± 12.2 | 39.1 ± 12.7 | 0.738 |
PO at 3 months | 42.1 ± 6.5 | 41.9 ± 6.0 | 44.3 ± 6.7 | 0.021 |
PO at 6 months | 42.1 ± 6.5 | 41.9 ± 6.0 | 44.3 ± 6.7 | 0.021 |
PO at 12 months | 50.2 ± 4.3 | 48.3 ± 3.2 | 55.2 ± 5.5 | < 0.001 |
PO at 24 months | 53.3 ± 3.3 | 48.7 ± 3.5 | 55.8 ± 3.1 | < 0.001 |
p value‡ | < 0.001 | < 0.001 | < 0.001 | |
(B) WOMAC (pain and function) | ||||
Pre-op | 60.8 ± 7.6 | 60.2 ± 8.1 | 61.8 ± 7.2 | 0.461 |
PO at 3 months | 42.9 ± 4.6 | 47.2 ± 4.1 | 39.8 ± 5.2 | < 0.001 |
PO at 6 months | 42.9 ± 4.6 | 47.2 ± 4.1 | 39.8 ± 5.2 | < 0.001 |
PO at 12 months | 40.5 ± 4.3 | 45.6 ± 4.1 | 34.1 ± 4.4 | < 0.001 |
PO at 24 months | 39.8 ± 4.1 | 44.6 ± 4.0 | 33.1 ± 4.1 | < 0.001 |
p value‡ | < 0.001 | < 0.001 | < 0.001 | |
(C) ROM of the knee joint | ||||
FC (°) | ||||
Pre-op | 9.4 ± 6.8 | 10.3 ± 9.3 | 8.5 ± 5.8 | 0.039 |
PO at 3 months | 4.5 ± 7.8 | 6.0 ± 7.3 | 3.5 ± 8.8 | 0.015 |
PO at 6 months | 4.5 ± 7.8 | 6.0 ± 7.3 | 3.5 ± 8.8 | 0.015 |
PO at 12 months | 4.3 ± 6.8 | 5.7 ± 6.5 | 2.1 ± 7.0 | < 0.001 |
PO at 24 months | 4.3 ± 6.2 | 5.6 ± 6.4 | 2.2 ± 6.1 | < 0.001 |
p value‡ | < 0.001 | < 0.001 | < 0.001 | |
FF (°) | ||||
Pre-op | 92.3 ± 7.9 | 78.4 ± 8.1 | 105.3 ± 7.4 | 0.027 |
PO at 3 months | 110.3 ± 8.9 | 108.6 ± 8.8 | 115.4 ± 9.2 | 0.01 |
PO at 6 months | 110.3 ± 8.9 | 108.6 ± 8.8 | 115.4 ± 9.2 | 0.01 |
PO at 12 months | 116.1 ± 7.3 | 110.4 ± 7.1 | 123.0 ± 7.4 | < 0.001 |
PO at 24 months | 117.4 ± 9.3 | 111.7 ± 9.1 | 122.8 ± 9.8 | < 0.001 |
p value‡ | < 0.001 | < 0.001 | < 0.001 | |